BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38745067)

  • 1. The STING inhibitor (ISD-017) reduces glomerulonephritis in 129.B6.Fcgr2b-deficient mice.
    Alee I; Chantawichitwong P; Leelahavanichkul A; Paludan SR; Pisitkun T; Pisitkun P
    Sci Rep; 2024 May; 14(1):11020. PubMed ID: 38745067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.
    Saisorn W; Saithong S; Phuengmaung P; Udompornpitak K; Bhunyakarnjanarat T; Visitchanakun P; Chareonsappakit A; Pisitkun P; Chiewchengchol D; Leelahavanichkul A
    Front Immunol; 2021; 12():669162. PubMed ID: 34248948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.
    Jhou JP; Chen SJ; Huang HY; Lin WW; Huang DY; Tzeng SJ
    Exp Mol Med; 2017 Sep; 49(9):e381. PubMed ID: 28960214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Lon protease promotes CD4
    Huang X; Liu Y; Ling G; Cao X
    Int Immunopharmacol; 2023 Oct; 123():110519. PubMed ID: 37531828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
    Wolf VL; Taylor EB; Ryan MJ
    Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology.
    Prabakaran T; Troldborg A; Kumpunya S; Alee I; Marinković E; Windross SJ; Nandakumar R; Narita R; Zhang BC; Carstensen M; Vejvisithsakul P; Marqvorsen MHS; Iversen MB; Holm CK; Østergaard LJ; Pedersen FS; Pisitkun T; Behrendt R; Pisitkun P; Paludan SR
    EBioMedicine; 2021 Apr; 66():103314. PubMed ID: 33813142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein.
    Panchanathan R; Shen H; Duan X; Rathinam VA; Erickson LD; Fitzgerald KA; Choubey D
    J Immunol; 2011 Jun; 186(12):6762-70. PubMed ID: 21551362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alone.
    Sharp PE; Martin-Ramirez J; Boross P; Mangsbo SM; Reynolds J; Moss J; Pusey CD; Cook HT; Tarzi RM; Verbeek JS
    Mol Immunol; 2012 Feb; 50(1-2):49-56. PubMed ID: 22244885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory IgG Fc receptor promoter region polymorphism is a key genetic element for murine systemic lupus erythematosus.
    Lin Q; Hou R; Sato A; Ohtsuji M; Ohtsuji N; Nishikawa K; Tsurui H; Amano H; Amano E; Sudo K; Nishimura H; Shirai T; Hirose S
    J Autoimmun; 2010 Jun; 34(4):356-63. PubMed ID: 19758787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus.
    Kikuchi S; Santiago-Raber ML; Amano H; Amano E; Fossati-Jimack L; Moll T; Kotzin BL; Izui S
    J Immunol; 2006 Mar; 176(5):3240-7. PubMed ID: 16493085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
    Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
    Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production.
    Rahman ZS; Niu H; Perry D; Wakeland E; Manser T; Morel L
    Genes Immun; 2007 Oct; 8(7):604-12. PubMed ID: 17713556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
    Kim K; Bang SY; Joo YB; Kim T; Lee HS; Kang C; Bae SC
    J Rheumatol; 2016 Jun; 43(6):1045-9. PubMed ID: 26980576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
    Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
    Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
    Jonsson CA; Svensson L; Carlsten H
    Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
    Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
    J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presumptive role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new mouse model with Fcγ receptor type IIb-deficient C57BL/6 genetic background.
    Sato-Hayashizaki A; Ohtsuji M; Lin Q; Hou R; Ohtsuji N; Nishikawa K; Tsurui H; Sudo K; Ono M; Izui S; Shirai T; Takai T; Nishimura H; Hirose S
    Arthritis Rheum; 2011 Oct; 63(10):2930-8. PubMed ID: 21953083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axl regulated survival/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis.
    Zhen Y; Ren Y; Medvedovic M; Adams DE; Wang D; Shao WH
    Arthritis Res Ther; 2022 Dec; 24(1):284. PubMed ID: 36578056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.